V11-06 Robotic Management of Rectourethral Fistula After Rezum Treatment

You have accessJournal of UrologyBPH/Male Voiding Dysfunction/Infection/Misc. Imaging (V11)1 May 2024V11-06 ROBOTIC MANAGEMENT OF RECTOURETHRAL FISTULA AFTER REZUM TREATMENT Valeria Celis, Veronica I. Rodriguez, Luis G. Medina, Desiree Sanchez, Luis Dubey, and Rene Sotelo Valeria CelisValeria Celis , Veronica I. RodriguezVeronica I. Rodriguez , Luis G. MedinaLuis G. Medina , Desiree SanchezDesiree Sanchez , Luis DubeyLuis Dubey , and Rene SoteloRene Sotelo View All Author Informationhttps://doi.org/10.1097/01.JU.0001009368.07681.43.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Rectourethral fistulas (RUF) carry significant morbidity for patients. The most prominent risk factors for this condition are related to therapeutic options for prostate cancer. Conversely, treatment options for BPH have not been traditionally linked to RUF, especially during the past years as BPH treatment options have evolved and become less invasive. For example, Rezum aims to decrease the obstruction caused by BPH by instilalling water vapor. It's been reported as a safe procedure with rather mild and infrequent adverse events. A RUF as a complication after Rezum therapy is a rare occurrence that prompts surgical management. Among these options, the robotic approach yields therapeutic benefits and less postoperative morbidity. This video's objectives are to describe RUF as a potential complication of Rezum, explain the detailed surgical management, and assess the results of this approach. METHODS: We describe the robotic management of RUF as a complication of Rezum therapy. In this case, such procedure took place with simultaneous biopsy, which later revealed prostate cancer. A detailed, step-by-step description of our management is provided along with outcomes. RESULTS: Robotic RUF repair is a safe and feasible procedure with simultaneous salvage prostatectomy. Discharge is within the first 3 days. Drains are removed during the first 2-3 weeks. A cystogram at the first month postoperative confirms anastomosis patency and allows foley removal. CONCLUSIONS: With a rise in endourological treatments for BPH, we should be on the lookout for rare but severe complications, as well as the management of these. Avoiding simultaneous biopsy and invasive treatments could prevent major complications, even with safe procedures. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e912 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Valeria Celis More articles by this author Veronica I. Rodriguez More articles by this author Luis G. Medina More articles by this author Desiree Sanchez More articles by this author Luis Dubey More articles by this author Rene Sotelo More articles by this author Expand All Advertisement PDF downloadLoading ...